Daniel Souery Selected Research

Nortriptyline (Aventyl)

1/2019	Effect of antidepressant switching between nortriptyline and escitalopram after a failed first antidepressant treatment among patients with major depressive disorder.
1/2019	Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder.
1/2016	Combining clinical variables to optimize prediction of antidepressant treatment outcomes.
12/2014	An inflammatory biomarker as a differential predictor of outcome of depression treatment with escitalopram and nortriptyline.
4/2011	Changes in body weight during pharmacological treatment of depression.
6/2010	History of suicide attempts among patients with depression in the GENDEP project.
11/2009	Body weight as a predictor of antidepressant efficacy in the GENDEP project.
11/2009	Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.
10/2009	Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial.
9/2009	Adverse reactions to antidepressants.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Souery Research Topics

Disease

39	Major Depressive Disorder (Major Depressive Disorders) 11/2022 - 09/2007
14	Treatment-Resistant Depressive Disorder 10/2021 - 07/2007
13	Mood Disorders (Mood Disorder) 01/2022 - 03/2002
9	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 06/2003
8	Depressive Disorder (Melancholia) 01/2021 - 07/2007
6	Mental Disorders (Mental Disorder) 07/2021 - 07/2003
5	Panic Disorder (Panic Attack) 12/2020 - 07/2007
4	Genetic Risk Score 01/2022 - 01/2017
4	Social Phobia 12/2020 - 07/2007
4	Anxiety Disorders (Anxiety Disorder) 01/2017 - 07/2003
3	Schizophrenia (Dementia Praecox) 04/2022 - 01/2017
3	Inflammation (Inflammations) 10/2021 - 12/2014
3	Agoraphobia 12/2020 - 01/2017
3	Drug-Related Side Effects and Adverse Reactions 01/2015 - 09/2009
3	Weight Gain 07/2011 - 09/2009
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2022 - 01/2017
2	Hypertension (High Blood Pressure) 01/2022 - 01/2019
2	Personality Disorders (Personality Disorder) 01/2019 - 07/2007
2	Sleep Initiation and Maintenance Disorders (Insomnia) 07/2011 - 09/2009
2	Body Weight (Weight, Body) 04/2011 - 11/2009
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 12/2020
1	Anhedonia 01/2018
1	Hypothyroidism 01/2018
1	Bulimia Nervosa 01/2017
1	Phobic Disorders (Phobia) 01/2017
1	Disease Susceptibility (Diathesis) 11/2016
1	Postpartum Depression (Post-Natal Depression) 11/2016
1	Dizziness (Lightheadedness) 07/2015
1	Weight Loss (Weight Reduction) 04/2011
1	Obesity 11/2009
1	Overweight 11/2009
1	Constipation 09/2009
1	Neurobehavioral Manifestations 03/2009
1	Mania (Manias) 11/2007
1	Darier Disease (Darier's Disease) 12/2003
1	Disease Progression 06/2003

Drug/Important Bio-Agent (IBA)

43	Antidepressive Agents (Antidepressants)IBA 11/2022 - 07/2007
14	Escitalopram FDA Link 01/2019 - 03/2009
11	Nortriptyline (Aventyl)FDA LinkGeneric 01/2019 - 03/2009
9	Antipsychotic Agents (Antipsychotics)IBA 11/2022 - 05/2012
6	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 08/2004
4	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 06/2022 - 08/2011
4	BenzodiazepinesIBA 12/2020 - 01/2017
3	Pregabalin (Lyrica)FDA Link 01/2022 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 07/2021 - 12/2014
3	Biological ProductsIBA 01/2021 - 06/2003
3	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2019 - 01/2016
3	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2014 - 07/2003
2	Pharmaceutical PreparationsIBA 10/2021 - 07/2011
2	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2019 - 04/2011
2	C-Reactive ProteinIBA 05/2017 - 12/2014
2	Carrier Proteins (Binding Protein)IBA 05/2015 - 07/2013
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 09/2013 - 05/2004
2	Phospholipases A2 (Phospholipase A2)IBA 08/2006 - 12/2003
1	Aripiprazole (Abilify)FDA Link 11/2022
1	Quetiapine Fumarate (Seroquel)FDA Link 11/2022
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2022
1	Glycogen Synthase Kinase 3 betaIBA 10/2021
1	rho-Associated KinasesIBA 10/2021
1	fasudil (AT 877)IBA 10/2021
1	EsketamineIBA 01/2021
1	Nasal SpraysIBA 01/2021
1	ChromatinIBA 01/2019
1	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2019
1	CMP- N- acetylneuraminate- poly- alpha- 2,8- sialosyl sialyltransferaseIBA 01/2019
1	LithiumIBA 12/2018
1	Tuberculin (PPD)IBA 11/2016
1	Transcription Factors (Transcription Factor)IBA 05/2015
1	Adenosine Monophosphate (AMP)IBA 05/2015
1	Cytochrome P-450 CYP2C19IBA 08/2013
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 08/2013
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 08/2013
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 08/2013
1	Cytochrome P-450 CYP2C9IBA 08/2013
1	Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA 07/2013
1	ElementsIBA 07/2013
1	Cyclic AMP (AMP, Cyclic)IBA 07/2013
1	Calcium Channels (Calcium Channel)IBA 06/2012
1	Serotonin (5 Hydroxytryptamine)IBA 01/2012
1	Desipramine (Pertofrane)FDA LinkGeneric 08/2011
1	Citalopram FDA LinkGeneric 08/2011
1	DysbindinIBA 12/2010
1	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 07/2010
1	Methylphenidate (Ritalin)FDA LinkGeneric 11/2007
1	corticotropin releasing factor-binding proteinIBA 09/2007
1	Substance PIBA 12/2005
1	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 10/2003
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2003
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 03/2002
1	Corticotropin-Releasing HormoneIBA 03/2002

Therapy/Procedure

5	Therapeutics 01/2021 - 07/2003
1	Wearable Electronic Devices 07/2021
1	Precision Medicine 01/2019
1	Drug Therapy (Chemotherapy) 12/2018
1	Secondary Prevention 11/2007